Position
Renaissance Technologies in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.9M$2.47 → $3.24
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.04M | $6.23M | — | — | — | 0.0% |
| Q1 2026 | 3.97M | $9.81M | $2.47 | $1.28M | $2.3M | 0.0% |
| Q2 2026 | 2.47M | $8M | $3.24 | $1.9M | −$3.71M | 0.0% |